Aggarwal Sumit 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Aggarwal Sumit
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-24−30,000→ 30,000 total→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2025-01-24+30,000→ 199,930 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.